AbbVie Aktie
| 202,14USD | 1,20USD | 0,60% |
WKN DE: A1J84E / ISIN: US00287Y1091
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 47 000 | 50 000 | 50 000 | 50 000 | 55 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,97 | 1,12 | 1,16 | 1,09 | 1,02 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 24 173 | 27 928 | 28 463 | 33 002 | 25 582 |
| Summe Anlagevermögen | 126 392 | 118 601 | 110 342 | 101 709 | 109 579 |
| Summe Aktiva | 150 565 | 146 529 | 138 805 | 134 711 | 135 161 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 137 468 | 131 093 | 121 518 | 124 314 | 131 797 |
| Summe Eigenkapital | 13 097 | 15 436 | 17 287 | 10 397 | 3 364 |
| Summe Passiva | 150 565 | 146 529 | 138 805 | 134 711 | 135 161 |
Adresse
| 1 North Waukegan Road, 60064-6400 North Chicago | |
| Telefon | +1 (847) 932-7900 |
| Internet | http://www.abbvie.com |
Management
|
Azita Saleki-Gerhardt
Chief Operations Officer & Executive VP |
|
Brett J. Hart
Independent Director |
|
Brian L. Durkin
Vice President |
|
Carrie Strom
Senior VP & President-Global Allergan Aesthetics |
|
Edward J. Rapp
Independent Director |
|
Esteban Plata
Vice President-Western Europe & Canada |
|
Frederick H. Waddell
Independent Director |
|
Glenn Fletcher Tilton
Independent Director |
|
Gregory Miley
Senior Vice President-Government Affairs |
|
Jennifer L. Davis
Independent Director |
|
Kevin K. Buckbee
Senior Vice President & Controller |
|
Latif Akintade
SVP-Medical Affairs & Health Economics |
|
Liz Shea
Senior Vice President-Investor Relations |
|
Melody B. Meyer
Independent Non-Executive Director |
|
Nicholas Donoghoe
Chief Business & Strategy Officer, Executive VP |
|
Perry C. Siatis
Secretary, Executive VP & General Counsel |
|
Rebecca Brown Roberts
Independent Director |
|
Richard A. Gonzalez
Executive Chairman |
|
Robert A. Michael
Chief Executive Officer & Director |
|
Robert J. Alpern
Independent Director |
|
Roopal Thakkar
Chief Scientific Officer, Executive VP-R&D |
|
Roxanne Schuh Austin
Lead Independent Director |
|
Sanjay Narayan
Chief Ethics & Compliance Officer, Senior VP |
|
Scott T. Reents
Chief Financial Officer & Executive Vice President |
|
Susan E. Quaggin
Independent Director |
|
Thomas C. Freyman
Independent Director |
|
Timothy J. Richmond
Chief Human Resources Officer & Executive VP |
|
William H. L. Burnside
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.